127 related articles for article (PubMed ID: 6689183)
1. Long-term effects of molsidomine on exercise tolerance in patients with exertional angina pectoris.
Kinoshita M; Sawamura M; Motomura M; Takayama Y; Kawaguchi Y; Kawakita S
Jpn Circ J; 1983 Dec; 47(12):1398-405. PubMed ID: 6689183
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
De Backer GG; Derese A
Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735
[TBL] [Abstract][Full Text] [Related]
3. Clinical and hemodynamic effects of the new dilator drug molsidomine.
Malcolm AD
Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
Rudolph W; Dirschinger J
Am Heart J; 1985 Mar; 109(3 Pt 2):670-4. PubMed ID: 3883733
[TBL] [Abstract][Full Text] [Related]
6. Molsidomine in the treatment of patients with angina pectoris.
Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
[TBL] [Abstract][Full Text] [Related]
7. Combination of metoprolol with molsidomine in the treatment of angina pectoris.
van Mantgem JP; Lie KI; Matroos AW
Eur J Clin Pharmacol; 1985; 28(2):109-11. PubMed ID: 3838725
[TBL] [Abstract][Full Text] [Related]
8. [Molsidomine in exertion angina].
Witchitz S; Kolsky H; Moisson P
Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):539-43. PubMed ID: 6689396
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and coronary effects of molsidomine at basal state, during atrial pacing, and during cold pressor test in patients with stable angina pectoris.
Juliard JM; Neukirch F; Zygelman M; Merillon JP; Michel PL; Pansard Y; Dahan M; Gourgon R
Am Heart J; 1985 Mar; 109(3 Pt 2):662-6. PubMed ID: 3838404
[TBL] [Abstract][Full Text] [Related]
10. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate (ISDN) during acute and short-term administration in stable angina pectoris.
Wagner F; Gohlke-Bärwolf C; Trenk D; Jähnchen E; Roskamm H
Eur Heart J; 1991 Sep; 12(9):994-9. PubMed ID: 1936012
[TBL] [Abstract][Full Text] [Related]
11. Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris.
Nechwatal W; Stauch M; Sigel H; Kress P; Bitter F; Geffers H; Adam WE
Clin Cardiol; 1981; 4(5):248-53. PubMed ID: 6895491
[No Abstract] [Full Text] [Related]
12. [Anti-ischemic effect of 8 mg molsidomin in retard form].
Blasini R; Brügmann U; Rudolph W
Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
[TBL] [Abstract][Full Text] [Related]
14. Increased exercise tolerance and reduced electrocardiographic ischemia with diltiazem in patients with stable angina pectoris.
Wagniart P; Ferguson RJ; Chaitman BR; Achard F; Benacerraf A; Delanguenhagen B; Morin B; Pasternac A; Bourassa MG
Circulation; 1982 Jul; 66(1):23-8. PubMed ID: 7083512
[TBL] [Abstract][Full Text] [Related]
15. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
Witchitz S; Kolsky H; Moisson P; Valette H
Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
[TBL] [Abstract][Full Text] [Related]
16. [Influence of molsidomine on exercise-ECG'S In coronary insufficiency (author's transl)].
Grewe N; Stauch M
Dtsch Med Wochenschr; 1977 Dec; 102(48):1758-63. PubMed ID: 923459
[TBL] [Abstract][Full Text] [Related]
17. A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.
Messin R; Fenyvesi T; Carreer-Bruhwyler F; Crommen J; Chiap P; Hubert P; Dubois C; Famaey JP; Géczy J
Eur J Clin Pharmacol; 2003 Jul; 59(3):227-32. PubMed ID: 12734607
[TBL] [Abstract][Full Text] [Related]
18. [Molsidomine: evaluation of a single dose using the exercise test].
Ruano J; Zueco J; Colman T; López C; Pajarón A
Rev Esp Cardiol; 1985; 38(2):93-7. PubMed ID: 3890039
[No Abstract] [Full Text] [Related]
19. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
Fach WA; Becker HJ
Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: a multicenter randomized double-blind crossover placebo-controlled trial.
Messin R; Karpov Y; Baikova N; Bruhwyler J; Monseu MJ; Guns C; Géczy J
J Cardiovasc Pharmacol; 1998 Feb; 31(2):271-6. PubMed ID: 9475269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
